Translation & Spin-offs

EXPLORE

FlexoSense is a spin-off from the National University of Singapore incorporated in 2016. The co-founders have experience in startups, R&D, business development, sales & marketing, operations, and finance.

The FlexoSense co-founders have had the privilege of being mentored by other startup entrepreneurs and key industry players. FlexoSense has been recognized through the JT Corporate Award and the Modern Aging Competition in Singapore. FlexoSense was one of the winners for IDTechEx Launchpad Berlin 2017.

The co-founders envision their sensors as enablers in sensing for healthcare devices, robotics, and consumer electronics.

FlexoSense uses patented technologies and advanced manufacturing methods to create flexible sensors. The flexible sensors, embedded within a skin-like elastomer, aim to enable digital health analytics with unparalleled ease and comfort.

Find out more HERE.

EXPLORE

Microtube Technologies is a spin-off from the National University of Singapore incorporated in 2018. It was selected as one of the Top 100 Science Spin-offs worldwide. The team fabricate ultrathin elastomeric microtubes and design microtubular sensors mainly for biomedical applications. With multiple patents filed, our ultrathin, highly stretchable, flexible, weavable and washable microtubular sensors have great potential for next-generation devices for precision health.

Find out more HERE.

EXPLORE

QuantumTX aims to extend the boundaries of human health and performance by awakening the cell’s silent capacity to regenerate. QuantumTX proprietary BICEPS devices deliver specific electromagnetic signals deep into the body to activate our cell’s natural biological pathways, safely and non-invasively. Initial clinical trials showed that short weekly BICEPS sessions improve muscle tone and hasten recovery for patients post-surgery​. Scientific and clinical research continues to optimise and demonstrate the benefits of BICEPS in the treatment of multiple diseases.

Find out more HERE.

EXPLORE

Privi Medical has developed a medical device to alleviate bleeding and pain caused by haemorrhoids, also known as piles.

This was in response to clinical need. While there are clinical interventions available to treat more severe hemorroids (grades 3-4), the choice of treatment options for less severe cases (grades 1-2) is very poor.

Patients with haemorrhoid symptoms often don’t want to go to the clinic or hospital and the treatments available over-the-counter are also mostly drugs or creams. The co-founders wanted to develop something safe and effective which patients can use at home to treat themselves.

The company, which was incorporated in 2015, was born out of the Singapore-Stanford Biodesign Fellowship – a year-long programme which aims to develop innovators in the medtech field.

Privi Medical’s three co-founders – Dr Dharmawan, Dr Benjamin Tee and Mr Prusothman Raja – are working to bring the product to market.

In January 2018, Privi Medical received FDA clearance for its InstaliefTM Hemorrhoids Treatment device.

Find out more HERE.